Anaesthetic Considerations for Rationalizing Drug Use in the Operating Theatre : Strategies in a Singapore Hospital During COVID-19
© Springer Nature Switzerland AG 2020..
COVID-19 patients in the critical care unit tend to have prolonged hospital stay requiring high doses of sedation and paralysis to treat acute respiratory distress syndrome, resulting in a shortage of these drugs. In our hospital, we have instituted strategies to rationalise drug and oxygen usage. This includes prioritising time-sensitive elective cases, reducing overall elective case load, favouring opioid-reduction strategies and usage of alternative anaesthetic agents not commonly used in ICU. Both intensive care physicians and anaesthesiologists have to cooperate on drug conservation as similar drugs are used in elective operating lists as in the ICU. Patient safety is of utmost importance and we should keep in mind some pitfalls and ethical concerns of these alternative strategies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 2(2020), 7 vom: 10., Seite 871-873 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Au Yong, Phui Sze Angie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anesthesia |
|---|
| Anmerkungen: |
Date Revised 18.02.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s42399-020-00345-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314115846 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314115846 | ||
| 003 | DE-627 | ||
| 005 | 20231225152037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-020-00345-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1047.xml |
| 035 | |a (DE-627)NLM314115846 | ||
| 035 | |a (NLM)32838142 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Au Yong, Phui Sze Angie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anaesthetic Considerations for Rationalizing Drug Use in the Operating Theatre |b Strategies in a Singapore Hospital During COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Springer Nature Switzerland AG 2020. | ||
| 520 | |a COVID-19 patients in the critical care unit tend to have prolonged hospital stay requiring high doses of sedation and paralysis to treat acute respiratory distress syndrome, resulting in a shortage of these drugs. In our hospital, we have instituted strategies to rationalise drug and oxygen usage. This includes prioritising time-sensitive elective cases, reducing overall elective case load, favouring opioid-reduction strategies and usage of alternative anaesthetic agents not commonly used in ICU. Both intensive care physicians and anaesthesiologists have to cooperate on drug conservation as similar drugs are used in elective operating lists as in the ICU. Patient safety is of utmost importance and we should keep in mind some pitfalls and ethical concerns of these alternative strategies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anesthesia | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Conservation | |
| 650 | 4 | |a Drug | |
| 650 | 4 | |a Intensive Care | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Rational Use | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Kwa, Charlene Wen Xian |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Xin Hui Diana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d 2019 |g 2(2020), 7 vom: 10., Seite 871-873 |w (DE-627)NLM300071965 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:7 |g day:10 |g pages:871-873 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s42399-020-00345-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 7 |b 10 |h 871-873 | ||